Story perspectives
Purdue Pharma Sentenced to Forfeit $225 Million in Opioid Settlement
4/21/2026
1 of 1
Story summary
- A judge is set to sentence Purdue Pharma to forfeit $225 million, finalizing a settlement over its opioid crisis role.
- The penalty is part of the 2020 agreement that includes up to $7 billion from the Sackler family.
- Purdue will cease operations and be replaced by Knoa Pharma.
- More than 54,000 claimants accepted the settlement, but some victims urge the Justice Department to pursue criminal charges against Sackler family members.
